Jamunarani Veeraraghavan

2.2k citations
36 papers · 880 indexed · h-index 17
Topics
HER2/EGFR in Cancer Research (18 papers)Advanced Breast Cancer Therapies (10 papers)Monoclonal and Polyclonal Antibodies Research (8 papers)
Partner nations
United StatesSpainItaly

In The Last Decade

Jamunarani Veeraraghavan

36 papers receiving 870 citations

Peers

Jamunarani Veeraraghavan
Comparison fields: 5 of 83
  • Molecular Biology 393
  • Oncology 346
  • Cancer Research 258
  • Pulmonary and Respiratory Medicine 192
  • Radiology, Nuclear Medicine and Imaging 165
Replace Jun Rao with:
Jun Rao China
Jing‐Wen Bai China
Adriana Amaro Italy
Merete Hektoen Norway
Danupon Nantajit United States
Hui Xing China
Haineng Xu China
Xiao-Feng Le United States
Subbulakshmi Virudachalam United States
Eugeni López‐Bonet Spain
Jamunarani Veeraraghavan relative to Jun Rao China Jun Rao's profile →
Citations per field
00.5×4.6×
Jun Rao · 1×
Citations per year

Countries citing papers authored by Jamunarani Veeraraghavan

Since Specialization
Citations

This map shows the geographic impact of Jamunarani Veeraraghavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamunarani Veeraraghavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamunarani Veeraraghavan more than expected).

Fields of papers citing papers by Jamunarani Veeraraghavan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamunarani Veeraraghavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamunarani Veeraraghavan. The network helps show where Jamunarani Veeraraghavan may publish in the future.

Co-authorship network of co-authors of Jamunarani Veeraraghavan

This figure shows the co-authorship network connecting the top 25 collaborators of Jamunarani Veeraraghavan. A scholar is included among the top collaborators of Jamunarani Veeraraghavan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamunarani Veeraraghavan. Jamunarani Veeraraghavan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 2
3 8
4 11
5 22
6 10
7 34
8 183
9 43
10 41
11 22
12 33
13 45
14 47
15 61
16 37
17 13
18 37
19 18
20 27

About Jamunarani Veeraraghavan

Jamunarani Veeraraghavan is a scholar working on Oncology, Molecular Medicine and Cancer Research, having authored 36 papers that have together received 880 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (18 papers), Advanced Breast Cancer Therapies (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). The work is most often cited by research in Cancer Research (258 citations), Oncology (346 citations) and Molecular Medicine (36 citations). Jamunarani Veeraraghavan has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Natarajan Aravindan, Rachel Schiff, Terence S. Herman, Mohan Natarajan, Mothaffar F. Rimawi, Carmine De Angelis, C. Kent Osborne, Vidyalakshmi Sethunath, Sheeja Aravindan and Rakhesh Madhusoodhanan. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026